Clinical Trial Update: Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of recombinant human alpha-mannosidase for Alpha-mannosidosis; the status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Recombinant Human Alpha-mannosidase (alpha-mannosidase)

Snippet

Sponsor: Zymenex A/S | Conditions: Alpha Mannosidosis | Phase 2 | Status: UNKNOWN